Showing results (241-250 of 263) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancerP Sabbatini, S M Larson, A Kremer, et al.Radiology|July 1, 1990
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancerH R Maxon, L E Schroder, S R Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupG Giaccone, T A Splinter, C Debruyne, et al.Blood|February 3, 1998
Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancerC I Rivas, J C Vera, F Delgado-López, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2018
Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC countsD Lorente, D Olmos, J Mateo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2012
Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapyC N Sternberg, A Molina, S North, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2000
Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigensZ G Wang, L J Williams, X F Zhang, et al.Nature Medicine|January 14, 1998
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progressionC N Papandreou, B Usmani, Y Geng, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2015
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trialsK Fizazi, T W Flaig, M Stöckle, et al.Oncology|January 1, 1992
Multicenter phase II study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.Pageof 27